Lung cancer is the leading cause of cancer deaths in the United States, as well as a huge problem globally. Therefore, research efforts for early and late stage lung cancer are focused on developing treatments that can improve survival rates.
Surgery remains the main option for treating stage I & II lung cancer; however for situations in which the patient is unable to be operated on, the disease is being treated with stereotactic radiation. This form of treatment functions similar to surgery, as it delivers a concentrated dose of radiation to the targeted area to eliminate the cancerous tumor.
For stage IV lung cancer, chemotherapy is the standard of care for a majority of the cases. Yet, new target agents have been developed to treat lung cancer patients who have markers for certain gene mutations, and have shown very successful outcomes.
As more and more gene mutations are found to be linked to lung cancer, research efforts have been poured into developing more, new target agents to treat the particular mutations. Although it has the highest mortality rates, research efforts and spending on lung cancer are significantly less than other common cancers such as breast and prostate.
Cone Health Cancer Center is actively involved in clinical trials that test and research new treatment advancements in lung cancer. Those who are diagnosed with lung cancer should ask their doctor about active clinical trials being conducted at their treatment center.
Taking a multidisciplinary approach to treating lung cancer, Cone Health Cancer Center assembles their team of surgeons, radiologists, medical oncologists, pathologists, pharmacists, radiation oncologists and other related healthcare professionals to meet in a council each week to develop a treatment plan for each, individual lung cancer patient.
Dr. Mohamed K. Mohamed is an oncology and hematology specialist at Cone Health Cancer Center and a leading expert on research and treatments in Lung Cancer. Dr. Mohamed is a 1984 medical school graduate of Ain Shams University. He completed his residency in internal medicine at Pitt County Memorial Hospital and completed a fellowship in hematology and oncology at University of Pittsburg Medical Center and Cancer Institute.